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Fairness seems like a simple concept understood even
by children, but ensuring fairness in resource alloca-
tion turns out to be quite difficult. Fairness can be
divided into criteria and process. To paraphrase the
esteemed philosopher Norman Daniels, we may never
agree on the criteria, but we should at least perceive
that the process is fair.1
The current primary criterion used for organ alloca-
tion in liver transplantation is based on the principle
of urgency, which is operationalized as the patient’s
probability of dying from liver disease in the near
future. In most patients, this is measured with the
Model for End-Stage Liver Disease (MELD) score. Like
any prognostic index, the MELD score works only to
predict a specific thing (death from liver disease) in a
specific population (cirrhosis with impaired synthetic
function). It does not correlate well with quality of
life,2 nor does it do a good job of predicting death
from miscellaneous complications of liver disease
such as hepatopulmonary syndrome or from other
conditions that would benefit from transplantation
such as amyloidosis. Thus, the transplant community
has needed to develop a process for prioritizing such
patients. Some of these complications, such as hepa-
tocellular carcinoma, are common enough that a
standardized exception score has been set. However,
various other complications (eg, cholangitis), which
are called nonstandardized exceptions or nonrecog-
nized exception diagnoses (non-REDs), are reviewed
on a case-by-case basis by regional review boards
(RRBs).
Is the MELD exception process fair? New information
provided by Goldberg et al.3 in this issue of Liver Trans-
plantation suggests that the answer is, unfortunately,
not really. The authors reviewed 58,641 candidates for
liver transplantation; on behalf of 4356 of these
patients (7.4%), at least 1 non-RED exception applica-
tion was made. Hierarchical regression techniques
were used to investigate the reasons for variation in
exception applications and to understand the extent to
which variation occurred at the patient, transplant cen-
ter, and regional levels. In other words, if rates of
exceptions vary by center, is this variation due to
between-region differences in the strictness of RRBs,
and does this strictness exert feedback regulation of
center behavior? Alternatively, could it just be that
some centers have sicker patients than others? The
authors found that although exception applications did
vary by region, as previously documented, there was a
3-fold greater variation by center that was independent
of the region in which the centers were located. Despite
adjustments for between-center differences in patient
characteristics, rates of exception applications varied
more than 4-fold between centers in the same region.
As might be expected, because approval decisions
occur at the regional level, between-center differences
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in approval rates were much smaller. These data pro-
vide compelling evidence that centers differ in their
behavior regarding the submission of exception appli-
cations on behalf of their patients and that this behav-
ior is not driven by variations in the severity of patient
illness or by the whims of local RRBs.
Concerns about the fairness of MELD exceptions
are further heightened by Goldberg et al.’s finding
that in a multivariate analysis, women, African Ameri-
cans, Hispanics, and patients with Medicaid insur-
ance were all statistically significantly less likely to
have an exception application, as shown in Table 6 of
their article.3 These are traditionally vulnerable popu-
lations, and all have been shown to be underserved
by the transplant system in various ways.4-6 On the
positive side, minorities and patients with Medicaid
insurance seemed to fare slightly better at the RRB
level, as shown in Table 7 of their article. Women,
however, not only were 21% less likely to have an
exception application (P50.001) but also were 14%
less likely to have their exception approved (P50.07).
This is somewhat surprising, in that it is common
knowledge that women tend to have slightly lower
MELD scores than men with liver disease of a given
severity because their serum creatinine levels are
lower.5 Further study is needed to understand the
reasons behind these disparities.
Why are physicians at one center much more likely to
submit exception applications than physicians at
another center? This finding could not be explained by
center-level differences in volume or the competitive-
ness of the local environment. Only the median match
MELD score was associated with a likelihood of a higher
submission rate, and the magnitude of this association
was small. I would theorize that these differences are
primarily due to differences in local culture and norms
of practice. Most transplant physicians spend the
majority of their career practicing at one center, and
many practice at the same center at which they com-
pleted their training. At national meetings, few of us
spend time comparing our rates of exception applica-
tions with our colleagues’ rates at other centers; in fact,
most of us can only guess at our own personal rates.
When deciding whether to apply for an exception on a
patient’s behalf, we habitually behave as we have
always behaved and similarly to how colleagues at our
own center behave. Such center-level differences have
been shown for other behaviors in liver transplantation,
such as organ utilization practices.7
In summary, the process for determining MELD
exceptions does not fully adhere to the accepted crite-
rion of urgency. A given patient’s probability of receiv-
ing a MELD exception is determined not just by his or
her probability of dying from liver disease but also by
his or her race/ethnicity, sex, socioeconomic status,
and geographic location. What then are some possible
solutions? Because most of the variation is at the cen-
ter level, a national review board would not solve the
problem. One solution is improved prognostic models.
It is possible that the upcoming incorporation of
serum sodium into the MELD score (the MELD-Na
score) will reduce the need for non-RED exceptions in
some patients, although this remains to be seen.
Another solution is the delineation of formal criteria
for RRBs to follow. One hypothesis for partially
explaining center differences is that centers with rep-
resentatives on RRBs have inside knowledge about
what types of applications are likely to receive a favor-
able review, and this makes these centers more likely
to submit applications. The 2006 consensus guideline
on MELD exceptions was developed as a review of the
available evidence and not as a working document for
RRBs.8 Perhaps it is time for the liver transplant com-
munity to develop a more granular set of protocols
and standards. Finally, the most powerful tool for
reducing center-level variability would be to provide
each center with feedback about its practices with
respect to national averages. Normative feedback has
long been recognized as a crucial component of
change in physician behavior,9 and I have argued that
it is underused in transplantation.7 Feedback would
at least promote consistency, which is an important—
and measurable—aspect of fairness.
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